Taken together, given that human disease, such as AD, is not easily defined by a single parameter (sex, age, Braak stage, Tau, etc.), we feel our blinded analysis of more than 30 subjects more accurately and appropriately demonstrates a correlation between changes in the available activity of 20S proteasome without a 19S cap and the severity of the disease. Here, MAPT is linked to Alzheimer disease.